Unlisted Deals:
ador powertron 500.00 (4,900.00 %) amol minechem 601.00 (0.17 %) anglo french drugs 950.00 (2.15 %) anugraha valve 510.00 (0.99 %) apl metals 40.00 (-2.44 %) apollo fashion 92.00 (-4.17 %) arkfin investments 50.00 arohan 250.00 (-1.96 %) assam carbon 310.00 (-1.59 %) avalokiteshvar 242.00 (0.83 %) axles india 680.00 (0.74 %) balmer lawrie 200.00 (-0.99 %) bharat hotels 375.00 (-1.32 %) bima mandi 235.00 (-2.08 %) bira 545.00 (-0.91 %) blsx limited 35.00 (2.94 %) boat 1,550.00 (-1.90 %) c & s electric 1,070.00 (1.90 %) cable corporation 24.50 (2.08 %) capgemini 14,600.00 (-1.02 %) care health 185.00 (-1.60 %) carrier aircon 550.00 (0.92 %) cial 470.00 (-1.05 %) csk 198.00 (-0.50 %) dalmia refract 270.00 (-1.82 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 445.00 (1.14 %) electronica plastic 4,500.00 (2.27 %) elgi ultra 400.00 elofic industries 2,850.00 (1.79 %) esl steel 42.00 (-2.33 %) fincare business 87.00 (1.16 %) fincare sfbl 205.00 (1.49 %) finopaytech limited 149.00 (-0.67 %) flipkart india 231,001.00 (0.00 %) frick india 3,500.00 (-1.41 %) gkn driveline 1,750.00 (2.94 %) goodluck defence 296.00 (-1.00 %) group pharma 300.00 gynofem healthcare 59.00 (-1.67 %) hazira cargo terminals limited 205.00 (1.49 %) hdb financial 1,210.00 (-1.22 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,300.00 (-2.59 %) hella india 900.00 (-2.17 %) hero fincorp 1,980.00 (-0.50 %) hexaware 985.00 (-0.51 %) hicks 1,600.00 (1.59 %) hira ferro 200.00 (2.56 %) honeywell electrical 7,200.00 (1.41 %) ikf finance 320.00 (-3.03 %) incred financial 10.00 (1.01 %) incred holdings 156.00 (-1.27 %) india carbon 1,120.00 (-1.32 %) india exposition 121.00 (0.83 %) indian potash 3,100.00 (-1.59 %) indian seamless 195.00 (2.63 %) indo alusys 25.75 (-0.96 %) indofil 1,430.00 (-0.69 %) infinite computer 405.00 (1.25 %) inkel 22.50 (-2.17 %) jana small finance bank 75.00 kel 575.00 (0.88 %) kial 137.00 (-0.72 %) klm axiva 15.50 (3.33 %) kurlon limited 1,275.00 (1.59 %) lava 45.00 (-2.17 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 875.00 (0.57 %) martin & harris 820.00 (-1.20 %) matrix gas 810.00 (-2.41 %) merino 3,250.00 (-1.52 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 435.00 (1.16 %) mobikwik 640.00 (-1.54 %) mohan meakin 2,400.00 (2.13 %) mohfl 13.25 (-1.85 %) msei 1.80 (-2.70 %) msil 34.00 (3.03 %) nayara energy 690.00 (1.47 %) nayara energy ncd 320.00 (1.59 %) ncdex 200.00 (-0.99 %) ncl buildtek 310.00 (-3.13 %) ncl holdings 106.00 (0.95 %) nsdl 850.00 (3.03 %) nse india 1,850.00 (-2.63 %) onix renewable 16,000.00 (6.67 %) orbis financial 400.00 (-1.23 %) oswal minerals 60.10 (-1.48 %) otis elevator 4,100.00 (2.50 %) oyo rooms 53.00 (-1.85 %) panasonic appliances 262.00 (0.77 %) paymate india 500.00 (-1.96 %) pharmeasy 8.50 (3.03 %) pharmed limited 620.00 (0.81 %) philips domestic 675.00 (-1.46 %) philips india 925.00 (-0.54 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 265.00 (1.92 %) rapido 16,650.00 (0.03 %) rasoi 82,000.00 (2.50 %) reliance gic 480.00 (-2.04 %) resins plastics 525.00 (-0.94 %) ring plus aqua 560.00 (1.82 %) rrp s4e innovation 300.00 (-3.23 %) sab miller 535.00 (0.94 %) sbi amc 2,650.00 (-1.12 %) sbi general insurance 621.00 (0.16 %) scottish assam 505.00 (1.00 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,325.00 (-1.85 %) smile microfinance 51.00 (-1.92 %) sterlite grid 5 275.00 (-3.51 %) sterlite power 590.00 (-1.67 %) studds 980.00 (3.16 %) svsml 315.00 (2.94 %) t stanes 800.00 (1.27 %) tata capital 900.00 (-1.10 %) trl krosaki 1,750.00 (-1.41 %) urban tots 64.00 (-1.54 %) utkarsh coreinvest 290.00 (-1.69 %) vikram solar 445.00 (-1.11 %) vivriti capital 1,040.00 (-0.95 %)
×

Ramaraju Surgical Annual Reports, Balance Sheet and Financials

The Ramaraju Surgical Cotton Mills Limited (Ramaraju Surgical) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
The Ramaraju Surgical Cotton Mills Limited

 

The Ramaraju Surgical Cotton Mills Balance Sheet (Rs in Lakhs)

Particulars

31-03-2024

31-03-2023

Non-Current Assets

 

 

Property, Plant & Equipments

27,857.40

29,727.20

Capital Work-in-Progress

230.81

917.02

Investment Property

5.24

5.43

Goodwill

1,951.50

1,951.50

Intangible assets

471.97

61.03

Investments in Associates

19,338.10

18,755.97

Other Investments

578.48

8.27

Other Financial Assets

433.33

761.62

Deferred Tax assets

1,116.01

487.19

Other Non-current assets

38.24

122.40

Current Assets

 

 

Inventories

11,560.21

12,973.32

Trade Receivables

4,638.23

3,811.44

Cash And Cash Equivalents

4,065.74

303.48

Bank balance other than cash and cash equivalents

5.64

7.11

Other Financial Assets

341.93

200.23

Current tax assets

119.28

67.08

Other Current assets

2,538.32

2,589.68

Total Assets

75,290.43

72,749.97

Equity

 

 

Equity Share Capital

581.5

399.78

Other Equity

25,599.26

25,855.02

Non-Controlling Interest

398.53

535.96

Non-Current Liabilities

 

 

Borrowings

23,482.29

22,236.52

Provisions

102.49

88.97

Deferred Tax Liabilities (Net)

9.85

-

Other non-current Liabilities

72.2

15.96

Current Liabilities

 

 

Borrowings

21,561.85

20,037.02

Total Outstanding dues of micro enterprises and small enterprises

66.47

316.22

Total outstanding dues of creditors other than micro enterprises and small enterprises

1,196.27

1,137.87

Other Financial Liabilities

1,172.99

963.13

Other Current Liabilities

655.91

772.48

Provisions

390.82

391.04

Total Equity and Liabilities

75290.43

72749.97

 The Ramaraju Surgical Cotton Mills Profit & Loss Statement (Rs in Lakhs)

Particulars

31-03-2024

31-03-2023

Income

 

 

Revenue from Operations

36,559.20

40,711.00

Other Income

579.18

268.21

Total Income

37,138.38

40,979.21

Expenses

 

 

Cost of material consumed

20,320.77

24,502.71

Purchase of stock-in-trade

1,700.77

1,111.75

Changes in Inventories of Finished goods and Work in-Progress Stock

(201.94)

(348.87)

Employee Benefit Expenses

5,594.48

4,925.42

Finance Cost

3,756.54

3,158.65

Depreciation and Amortisation Expenses

3,543.14

4,205.75

Other Expenses

7,451.13

7,310.67

Total Expenses

42,164.89

44,866.08

Profit /(Loss) before Tax

(5,026.51)

(3,886.87)

Excess Income Tax provision related to earlier years withdrawn

(82.50)

(5.83)

Deferred Tax

(1,033.86)

(915.39)

Mat Credit (taken)/withdrawn related to earlier year

414.89

507.5

Total tax Expenses

(701.47)

(413.72)

Profit/(Loss) before share of profit of associates

(4,325.04)

(3,473.15)

Share of Net Profit after tax of associates accounted using equity method

550.62

547.75

Profit for the Year

(3,774.42)

(2,925.40)

Other Comprehensive Income

 

 

Remeasurement (Losses) on defined benefit obligation (net)

(26.70)

(34.63)

Less: Income Tax Savings

(9.33)

(10.08)

Add: Deferred Tax (including MAT Credit)

9.33

10.08

Fair Value gain on equity Instruments through OCI (net)

 (0.26)

 (3.83)

Share of OCI of Associates accounted for using the equity method

100.84

0.24

OCI-Foreign currency translation

 (8.68)

3.53

Total Comphrensive Income/(Loss) for the year

 (3,709.22)

 (2,960.09)

Earnings per share (Basic & Diluted)

 (93.94)

 (73.46)

 The Ramaraju Surgical Cotton Mills Consolidated Cash Flow Statement (Rs in Lakhs)

 

Particulars 31-03-2024 31-03-2023
Cash flows from Operating Activities    
Net Profit / (Loss) before tax (5,026.51) (3,886.87)
Depreciation & Amortisation 3,543.14 4,205.75
Finance Cost 3,756.54 3,158.65
Interest Received (238.62) (223.32)
(Profit) / Loss on Sale of Assets (66.04) (36.72)
Government Grants (1.45) (1.45)
Bad Debts - 54.12
Operating Profit before Working capital Changes 1,967.06 3,270.16
Trade Receivables (826.79) (88.80)
Inventories 1,413.11 (2,639.33)
Loans and Advances 2.07 225.91
Trade Payables & Current Liabilities (0.37) (1,251.62)
Income Tax Paid (Net) 125.38 (67.07)
Net Cash Flows from / (used in) Operating Activities 2,680.46 (550.75)
Cash flows from Investing Activities    
Purchase of Property, Plant and Equipments,lntangible Asset and Investment Property Net of Capital Subsidies (Including Capital work-in-progress and Capital advance and payable for capital goods) (1,743.52) (6,845.14)
Investment in Shares (422.43) (212.15)
Proceeds from Sale Property, Plant and Equipments 495.85 195.64
Interest Received 238.62 22.69
Dividend Received - 102.44
Net Cash Flows from / (used in) Investing Activities (1,431.48) (6,736.52)
Cash Flows from Financing Activities :    
Proceeds from right issue , Net of issue expenses 3,655.17 -
Proceeds from Long Term Borrowings 6,367.11 14,315.39
Repayment of Long Term Loan (5,121.34) (6,122.11)
Proceeds / (Repayment) of Deposits - Related Parties - (878.03)
Proceeds / (Repayment) of Short Term Borrowings (Net) 1,524.83 2,385.61
Non Controlling Interest (137.43) 3.52
Payment Dividend (19.99) (39.47)
Finance Cost (3,756.54) (3,008.66)
Net Cash Flows from / (used in) Financing Activities 2,511.81 6,656.25
Net Increase in Cash and Cash Equivalent                      3,760.79 (631.02)
Opening balance of Cash and Cash Equivalents                      310.59 941.61
Closing balance of Cash and Cash Equivalents                     4,071.38 310.59

 Here is a summary of the Cash Flow Statement for the years 2024 and 2023:

Operating Activities:

The company faced a significant loss before tax of ₹5,026.51 lakhs, a deterioration from the previous year 's loss of ₹3,886.87 lakhs. Despite this, the operating profit before working capital changes was positive at ₹1,967.06 lakhs, though it fell sharply from ₹3,270.16 lakhs in 2023. The decrease in operating profit before working capital changes reflects ongoing operational challenges.

Depreciation & Amortization decreased to ₹3,543.14 lakhs from ₹4,205.75 lakhs, suggesting a reduction in depreciation charges, possibly due to lower capital expenditure. Finance costs rose to ₹3,756.54 lakhs from ₹3,158.65 lakhs, indicating increased borrowing costs. Interest received was slightly higher at ₹238.62 lakhs compared to ₹223.32 lakhs, while the profit/loss on the sale of assets worsened to a loss of ₹66.04 lakhs from ₹36.72 lakhs.

Working capital adjustments showed significant fluctuations: Trade Receivables increased by ₹826.79 lakhs, a sharp contrast to a decrease of ₹88.80 lakhs in 2023, indicating issues in collecting receivables. Inventories rose by ₹1,413.11 lakhs, reversing the previous year 's decrease of ₹2,639.33 lakhs, likely reflecting inventory buildup. Loans and Advances saw a minor increase of ₹2.07 lakhs, whereas Trade Payables & Current Liabilities remained largely unchanged, showing a modest decrease of ₹0.37 lakhs. The company paid net income taxes of ₹125.38 lakhs, compared to a refund of ₹67.07 lakhs in the previous year.

Investing Activities:

The company 's investment activities involved substantial expenditures and receipts. The purchase of Property, Plant, and Equipment, including intangible assets and capital advances, amounted to ₹1,743.52 lakhs, a reduction from ₹6,845.14 lakhs, suggesting lower capital spending. Investment in Shares increased to ₹422.43 lakhs from ₹212.15 lakhs. The company received ₹495.85 lakhs from the sale of Property, Plant, and Equipment, a significant increase from ₹195.64 lakhs in the previous year. Interest received from investments increased to ₹238.62 lakhs, while dividend received was nil compared to ₹102.44 lakhs in 2023.

Overall, the net cash used in investing activities was ₹1,431.48 lakhs, a notable improvement from ₹6,736.52 lakhs in 2023, reflecting a reduced outflow in capital expenditures.

Financing Activities:

Financing activities saw substantial changes, including proceeds from a right issue of ₹3,655.17 lakhs, which was not present in 2023. The company secured ₹6,367.11 lakhs from long-term borrowings, a decrease from ₹14,315.39 lakhs in the prior year. Repayments of long-term loans amounted to ₹5,121.34 lakhs, compared to ₹6,122.11 lakhs in 2023. There were no proceeds from or repayments of deposits from related parties, unlike the previous year’s repayment of ₹878.03 lakhs. The company had a net inflow of ₹1,524.83 lakhs from short-term borrowings, a decrease from ₹2,385.61 lakhs. There was a slight outflow of ₹137.43 lakhs related to non-controlling interests, contrasting with an inflow of ₹3.52 lakhs in 2023. Dividend payments were reduced to ₹19.99 lakhs from ₹39.47 lakhs, and finance costs increased to ₹3,756.54 lakhs from ₹3,008.66 lakhs.

The net cash flow from financing activities was ₹2,511.81 lakhs, down from ₹6,656.25 lakhs, reflecting a lower inflow primarily due to reduced borrowings and financing activities.

Overall Cash Position:

The company experienced a significant increase in cash and cash equivalents, with a net increase of ₹3,760.79 lakhs, compared to a decrease of ₹631.02 lakhs in 2023. The opening balance of cash and cash equivalents was ₹310.59 lakhs, which grew to ₹4,071.38 lakhs by year-end, showing a strong improvement in liquidity.

 Financial Ratios of The Ramaraju Surgical Cotton Mills

Particulars

2024

2023

Debtors Turnover ratio (Days)

52

36

Inventory Turnover ratio (Days)

120

101

Interest Coverage ratio

(0.17)

(0.12)

Current Ratio

1.19

1.02

Debt-Equity ratio

4.65

4.38

Operation Profit Margins

8.34

9.64

Net profit Margin

(10.41)

(7.36)

Return on Net worth

(41.60)

(28.70)

Total Debt/EBITDA

14.12

10.02

Return on Capital

(0.02)

0.33

Here is a summary of the financial and operational metrics for The Ramaraju Surgical Cotton Mills Limited for the year 2024 & 2023:

Debtors Turnover Ratio (Days):

The Debtors Turnover Ratio measures how efficiently a company collects receivables. It is expressed in days, indicating the average number of days it takes to collect payment from customers. For 2024, the ratio is 52 days, up from 36 days in 2023. This increase suggests a slower collection period, indicating potential issues with receivables management or credit policies, which may be affecting liquidity and operational efficiency.

Inventory Turnover Ratio (Days):

The Inventory Turnover Ratio, expressed in days, shows the average time inventory remains unsold. In 2024, it stands at 120 days, compared to 101 days in 2023. This increase in days signifies slower inventory turnover, possibly due to higher stock levels or decreased sales efficiency. It may suggest potential overstocking or declining demand for the company 's products, impacting overall working capital.

Interest Coverage Ratio:

The Interest Coverage Ratio assesses a company 's ability to meet its interest obligations from operating income. For 2024, the ratio is -0.17, compared to -0.12 in 2023. Both figures are negative, indicating that the company’s operating income is insufficient to cover its interest expenses. This worsening ratio highlights severe financial distress and a higher risk of default on interest payments.

Current Ratio:

The Current Ratio measures a company 's ability to cover short-term liabilities with short-term assets. In 2024, the ratio is 1.19, up from 1.02 in 2023. Although the increase suggests improved liquidity and a stronger ability to meet short-term obligations, a ratio above 1.0 indicates that the company has more current assets than current liabilities, which is generally favorable.

Debt-Equity Ratio:

The Debt-Equity Ratio indicates the proportion of debt used relative to equity in financing the company’s assets. For 2024, the ratio is 4.65, compared to 4.38 in 2023. The increase reflects a higher reliance on debt relative to equity, suggesting elevated financial leverage. This higher ratio increases the company 's financial risk, as it indicates a greater burden of debt compared to shareholder equity.

Operating Profit Margin:

The Operating Profit Margin measures the percentage of revenue that remains after covering operating expenses. In 2024, the margin is 8.34%, down from 9.64% in 2023. The decrease indicates a decline in operating profitability, possibly due to rising operating costs or lower revenue, which could negatively impact overall financial performance.

Net Profit Margin:

The Net Profit Margin shows the percentage of revenue remaining after all expenses, including taxes and interest. For 2024, it is -10.41%, worsening from -7.36% in 2023. The negative margin signifies that the company is not profitable, with losses growing compared to the previous year. This decline in profitability could be due to high operating costs, financial expenses, or other factors impacting the bottom line.

Return on Net Worth:

The Return on Net Worth ratio measures how effectively the company uses shareholders ' equity to generate profit. In 2024, it stands at -41.60%, compared to -28.70% in 2023. The larger negative return indicates that the company is generating substantial losses relative to its net worth, reflecting poor financial performance and inefficient use of equity.

Total Debt/EBITDA:

This ratio evaluates the company 's total debt relative to its earnings before interest, taxes, depreciation, and amortization (EBITDA). For 2024, it is 14.12, significantly higher than 10.02 in 2023. The increased ratio indicates a higher level of debt relative to earnings, suggesting that the company may struggle to service its debt and is facing increased financial pressure.

Return on Capital:

The Return on Capital measures the return generated on capital employed in the business. In 2024, it is -0.02%, down from 0.33% in 2023. The negative return indicates that the company is not generating a positive return on its capital investments, reflecting inefficiencies and poor capital utilization that contribute to financial underperformance.

 

 

 

Ramaraju Surgical Annual Report

The Ramaraju Surgical Annual Report 2023-24

Download

The Ramaraju Surgical Annual Report 2022-23

Download

The Ramaraju Surgical Annual Report 2021-22

Download

The Ramaraju Surgical Annual Report 2020-21

Download

Ramaraju Surgical Financials 2023-24

Download

Ramaraju Surgical Annual Report 2022-23

Download

Financial results for the Quarter and half year ended 30 Sept 2024

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha

News Alert